Cooperative research projects
Charité – Universitätsmedizin Berlin pursues a wide range of cooperative projects, in particular those promoting the mutual exchange of findings from basic biomedical research, clinical research and clinical application. The future of research lies in collaboration – be it through collaborative research groups, joint professorial appointments, cooperative framework agreements with industrial partners or the translation of research findings via the technology transfer process.
Health care research at the Berlin Institute of Health (BIH)
When Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) joined forces to launch the Berlin Institute of Health (BIH), both institutions showed their firm commitment to a new path of institutional cooperation. By combining their respective expertise and resources on a regional level, Charité and MDC have produced permanent structures that cement Berlin's reputation as a natural venue for translational research excellence with international appeal.
Interdisciplinary research projects
Researchers from Charité are involved in many research collaborations and interdisciplinary projects. They work with university-based and non-university-based partners, as well as partners with close links to industry, including:
- The German Heart Center Berlin (DHZB), a high-volume center for the treatment of cardiovascular, respiratory system and vascular disorders, the implantation of ventricular assist devices, and heart and lung transplants.
- The German Rheumatism Research Center (DRFZ), a joint institution of Charité and Leibnitz Association, and one of the internationally leading institutes in the fields of immunology, experimental rheumatology and the epidemiology of rheumatic diseases.
- Helmholtz-Zentrum Geesthacht (HZG), an interdisciplinary translational center which, in conjunction with Charité, develops innovative therapies based on the body's capacity to heal itself. The research is taking place at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), an institution jointly owned with Charité.
- The Max Delbrück Center for Molecular Medicine (MDC), with whom Charité joined forces to operate the BIH and the Experimental and Clinical Research Center (ECRC) for translational clinical research.
Partner for pioneering cooperative projects
Charité prides itself on being a reliable partner for both research organizations and private companies. Due to its enviable position as a leader in health care provision, research, and teaching, Charité is able to pioneer new forms of cooperative arrangements. One example of such an innovative partnership is the long-term cooperative agreement between Charité and the Max Planck Society for the Advancement of Science, which includes the creation of joint professorships. Charité – Universitätsmedizin Berlin is also involved in various forms of cooperative partnerships with companies from the health care industry, medical care providers, and biomedical companies. Charité cooperates with pharmaceutical companies in order to develop and market new medicinal products, and with technology manufacturers in order to develop new devices and therapies. In conjunction with Vivantes, Charité is also in the process of developing the largest hospital-based laboratory in Europe.